Key facts
- It has raised $720K; the latest was Early Stage VC ($720K) in Dec 2024.
- Notable investors include Gnist Capital, Startuplab Ventures, Tidligfase Fondet, Ystvika Holding.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Lybe Scientific
- ·The full record, as it builds
Funding rounds
No funding rounds for Lybe Scientific are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lybe Scientific
Developer of highly sensitive and time-saving sample preparation products designed for a wide range of nucleic acid-based applications. The company's products can be used within various life science research applications, in vitro diagnostics, and fish health and aquaculture diagnostics, enabling clinicians to provide efficient and easy extraction of high-integrity nucleic acids, allowing for accurate and sensitive downstream analyses
- Sector
- Healthcare
- HQ
- Trondheim, Norway
- Founded
- 2021
- Employees
- 7
- Website
- lybescientific.com/
- Ownership
- Privately Held (backing)
Lybe Scientific doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lybe Scientific shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lybe Scientific in its N-PORT filings yet. We sweep new filings monthly.